UNSPSC 51281607: Gentamicin

This classification denotes an aminoglycoside antibiotic with the molecular formula C21H43N5O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier T6Z9V48IKG, more generally known as gentamicin. European Medicines Agency schedules gentamicin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02326MIG. The term GENTAMICIN is an International Non-Proprietary Name or INN. GENTAMICIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Most nations schedule gentamicin under HS 29419000 and SITC 54139. As of Q4 2014, GENTAMICIN remains the US FDA Preferred Term for this commodity. Gentamicin bears US NLM identifiers UMLS ID C0017436 and NCI Concept Code C519. SMILES: CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC.*.

UNSPSC 51281607 Gentamicin is a Commodity code that nominally covers a specific aminoglycoside antibiotic, yet recent state and local procurement activity under this code shows minimal direct alignment with gentamicin itself. The recent opportunities posted under this code span medical and pharmaceutical procurement more broadly—including naloxone and drug deactivation systems, generic multi-source pharmaceuticals and OTC products through cooperative purchasing, medical and first aid supplies for emergency response, and exploratory vendor capability assessments for direct-to-manufacturer prescription programs. State and local issuing bodies soliciting under this code include county health departments (Seminole County, Florida), municipal fire departments (City of Tampa), state health and human services agencies (Texas HHS Commission), and multi-state cooperative purchasing alliances (MMCAP, administered through the Minnesota Department of Administration). The mix reflects both direct procurement by individual jurisdictions and aggregate buying through cooperative vehicles that serve multiple participating states and localities.

Recent activity concentrates in Florida, Texas, and the Upper Midwest, with the most recent and concrete opportunity being Seminole County's IFB60459723LAS (posted June 30, 2026, due July 26, 2026), a sealed-bid solicitation for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The City of Tampa's IFB 26P00145 (posted March 25, 2026, due March 13, 2026) sought 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division at an estimated contract value of $700,000.00, designated as a sheltered market for certified Small Local Business Enterprises with a 5 percent bid discount. MMCAP's RFP for generic multi-source pharmaceuticals and OTC products (posted January 20, 2026, proposals due March 26, 2026) targets manufacturers supplying through three authorized wholesalers across participating state and local government facilities. The code itself appears to be a taxonomy mismatch with actual current procurement activity—gentamicin-specific opportunities do not surface in the recent solicitation records, suggesting the code may be applied inconsistently or that recent buying under it encompasses the broader medical and pharmaceutical supply landscape rather than the specific drug product named.